CRY2 is mutated in human bladder, colorectal, breast, stomach, melanoma, and head and neck cancers.Cry2 mutation in MYC-transformed fibroblasts suppressedp53 gene expression and enhances growth. This evidence concerns the gene MYC and melanoma.